# Mikhail Kosiborod
Các tập podcast hàng đầu
Đã cập nhật:
Top podcast episodes featuring mikhail kosiborod.
Circulation January 16, 2024 Issue
This week, please join author Mikhail Kosiborod and Associate Editor Brendan Everett as they discuss the article "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF…
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: the STEP-HFpEF and STEP-HFpEF DM randomised trials - report from ACC2024
Professor Mikhail Kosiborod shared his insights onthe STEP-HFpEF and STEP-HFpEF DM randomised trials.
Discussed studies:
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised tri…
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
CME credits: 0.25
Valid until: 26-02-2025
Claim your CME credit at https://reachmd.com/programs/cme/case-based-management-of-hyperkalemia-to-optimize-raasi-therapy-in-patients-with-ckd/16624/
Delve into refining the management of hyperkalemia in CKD patients and their associated comorbidi…
Updates from the STEP-HFpEF Trial | ESC 2024
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Mikhail Kosiborod, MD, FACC discuss an exciting secondary analysis of the STEP-HFpEF program, shedding light on the groundbreaking findings related to heart failure and obesity.
Clinical trial updates on the GLP-1 receptor agonists - report from ESC2024
Professor Mikhail Kosiborod provides a summary of the clinical trial updates on the GLP-1 receptor agonists.
Video: https://medicaldigest.org/scientific-contents/interview:clinical-trial-updates-glp-1-receptor-agonists
JACC - Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure
JACC Associate Editor Michelle M. Kittleson, MD, PhD, FACC, interviews author Mikhail Kosiborod, MD, FACC about his REALIZE-K study published in JACC and presented at AHA. In participants with HFrEF and hyperkalemia, SZC led to large improvements in the percentage of participants with normokalemia …
The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes
In this interview, Drs. Richard Chazal and Mikhail Kosiborod explore the rapidly evolving therapeutic landscape of obesity, with a particular focus on the cardiovascular benefits of emerging treatments. They delve into the impact of sodium-glucose co-transporter-2 (SGLT-2) inhibitors and glucagon-l…
Targeting Obesity to Treat Heart Failure - With Preserved Ejection Fraction (HFpEF)
Watch the full video on YouTube to explore the latest insights into heart failure with preserved ejection fraction (HFpEF) and the impact of GLP-1 receptor agonists. Discover how weight loss and metabolic therapies could transform treatment for people with diabetes, obesity, and heart failure.
You…
Special Edition: Obesity—The Changing Landscape
In the first episode of this series on Obesity, our host is joined by Dr. Mikhail Kosiborod to discuss the evolving science and cardiometabolic diseases associated with obesity.
This special episode is sponsored with support from AstraZeneca.
Presented by:
Neil Skolnik, MD, Professor of Family a…
CÔNG CỤ TÌM KIẾM PODCAST
Bạn có thể sử dụng trang web của chúng tôi để tìm kiếm các podcast3,828,637và các tập196,462,835theo người, địa điểm hoặc chủ đề.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
CHỈNH SỬA
Cảm ơn bạn đã giúp cơ sở dữ liệu podcast luôn cập nhật.
